Sarepta Therapeutics, Inc. (SRPT) short interest & options flow
NASDAQSarepta Therapeutics heads into its November 4 earnings report with nearly a quarter of its free float sold short, a stock down 19% over the past month, and a Street that has spent the past two weeks trimming price targets rather than defending the name. The short position here is genuinely material. At 23.5% of free float, with around 24.6 million shares short, SRPT sits among the…
- Market cap
- $1.91B
- Next earnings
- 24 Feb 2027
Key data as of 7 Nov 2026

SRPT news and analysis
RSSNo long-form analysis yet for SRPT. Pulse alerts and the live data picture are available on ORTEX.
Open SRPT on ORTEX →Want the live picture for SRPT?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SRPT — free to start on ORTEX.
Sign up for free →Open SRPT on ORTEX